Lightning Round OT: Virnetx, Teva Pharmaceutical and More

Tuesday, 16 Nov 2010 | 6:55 PM ET
Lightning Round OT
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Virnetx : Cramer would not buy this stock because of a possible merger and acquisition. If he were to invest in a company because of M&A, he would look for a high-yielding name.

Teva Pharmaceutical : The health care sector is bad and investors continue to sell this name, so Cramer can't recommend it. He recommends trying oil names instead.

Worldwide Wrestling Entertainment : The "Mad Money" host said this stock lacks growth. Try MarkWest Energy Partners instead.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change


Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.